Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serotonergic dysfunction in depression associated with Parkinson's disease.

E F McCance-Katz1, K L Marek, L H Price

  • 1Connecticut Mental Health Center, Department of Psychiatry, New Haven.

Neurology
|September 1, 1992
PubMed
Summary

Parkinson's disease patients experiencing depression may have serotonin imbalances. Lowering serotonin levels temporarily worsened depression, while restoring them improved symptoms, suggesting a link.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early life adversity and telomere length: a meta-analysis.

Molecular psychiatry·2017
Same author

Methylation of the leukocyte glucocorticoid receptor gene promoter in adults: associations with early adversity and depressive, anxiety and substance-use disorders.

Translational psychiatry·2016
Same author

Antiglucocorticoids as Treatments for Depression : Rationale for Use and Therapeutic Potential.

CNS drugs·2015
Same author

Is S-Adenosyl Methionine (SAMe) for Depression Only Effective in Males? A Re-Analysis of Data from a Randomized Clinical Trial.

Pharmacopsychiatry·2015
Same author

Exaggerated smooth muscle contraction segments on esophageal high-resolution manometry: prevalence and clinical relevance.

Neurogastroenterology and motility·2014
Same author

Reproducibility patterns of multiple rapid swallows during high resolution esophageal manometry provide insights into esophageal pathophysiology.

Neurogastroenterology and motility·2014

Area of Science:

  • Neuroscience
  • Psychiatry
  • Clinical Medicine

Background:

  • Parkinson's disease (PD) is a neurodegenerative disorder.
  • Depression is a common comorbidity in Parkinson's disease.
  • Serotonin is a neurotransmitter implicated in mood regulation.

Observation:

  • A 55-year-old male patient with Parkinson's disease and major depression was treated with fluvoxamine.
  • Fluvoxamine, a selective serotonin reuptake inhibitor, improved depressive symptoms.
  • Tryptophan depletion testing acutely lowered central serotonin levels.

Findings:

  • Tryptophan depletion transiently exacerbated the patient's depressive symptoms.
  • Subsequent tryptophan repletion resolved the exacerbated depression.
  • This suggests a causal role for serotonergic dysfunction in PD-related depression.

Related Experiment Videos

Implications:

  • Serotonergic dysfunction may be a key factor in the etiology of depression in Parkinson's disease.
  • Targeting serotonin pathways could be a therapeutic strategy for depression in PD patients.
  • Further research into the neurochemical underpinnings of PD comorbidities is warranted.